NewAmsterdam Pharma Co. NV (NAMS)
21.16
-1.20
(-5.37%)
USD |
NASDAQ |
Sep 15, 16:00
22.22
+1.06
(+5.01%)
Pre-Market: 08:02
NewAmsterdam Pharma Market Cap : 2.490B for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 2.490B |
| September 14, 2026 | 2.631B |
| September 11, 2026 | 2.682B |
| September 10, 2026 | 2.572B |
| September 09, 2026 | 2.681B |
| September 08, 2026 | 3.015B |
| September 04, 2026 | 2.988B |
| September 03, 2026 | 3.041B |
| September 02, 2026 | 3.011B |
| September 01, 2026 | 2.932B |
| August 31, 2026 | 2.981B |
| August 28, 2026 | 3.047B |
| August 27, 2026 | 3.152B |
| August 26, 2026 | 3.224B |
| August 25, 2026 | 3.217B |
| August 24, 2026 | 3.159B |
| August 21, 2026 | 3.279B |
| August 20, 2026 | 3.268B |
| August 19, 2026 | 3.357B |
| August 18, 2026 | 3.206B |
| August 17, 2026 | 3.165B |
| August 14, 2026 | 3.174B |
| August 13, 2026 | 3.138B |
| August 12, 2026 | 3.274B |
| August 11, 2026 | 3.250B |
| Date | Value |
|---|---|
| August 10, 2026 | 3.292B |
| August 07, 2026 | 3.290B |
| August 06, 2026 | 3.255B |
| August 05, 2026 | 3.226B |
| August 04, 2026 | 3.241B |
| August 03, 2026 | 3.234B |
| July 31, 2026 | 3.241B |
| July 30, 2026 | 3.320B |
| July 29, 2026 | 3.255B |
| July 28, 2026 | 3.264B |
| July 27, 2026 | 3.525B |
| July 24, 2026 | 3.457B |
| July 23, 2026 | 3.563B |
| July 22, 2026 | 3.698B |
| July 21, 2026 | 3.772B |
| July 20, 2026 | 3.461B |
| July 17, 2026 | 3.695B |
| July 16, 2026 | 3.622B |
| July 15, 2026 | 3.730B |
| July 14, 2026 | 3.883B |
| July 13, 2026 | 3.882B |
| July 10, 2026 | 4.113B |
| July 09, 2026 | 4.190B |
| July 08, 2026 | 4.179B |
| July 07, 2026 | 4.315B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 259.66M |
| Pharming Group NV | 746.71M |
| argenx SE | 60.63B |
| Ionis Pharmaceuticals, Inc. | 7.826B |
| Arcutis Biotherapeutics, Inc. | 2.953B |
Market Cap Related Metrics
| PS Ratio | 355.45 |
| PEG Ratio | -0.2772 |
| Price to Book Value | 3.943 |
| Price | 21.16 |
| Earnings Yield | -10.29% |
| PEGY Ratio | -0.2772 |